Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.57 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | F7 | P08709 | 3/20 | 0.57 |
| ▸ | F3 | P13726 | 3/20 | 0.57 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.57 |
| ▸ | PPARG | P37231 | 3/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | PPARD | Q03181 | 2/20 | 0.57 |
| ▸ | PPARA | Q07869 | 2/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL892781 | 1.00 | ALDH1A1 (0.57) | ALDH1A1CYP19A1MAPTF7F3 | |
| SCHEMBL469265 | 0.95 | ALDH1A1 (0.55) | ALDH1A1CYP19A1MAPTF7F3 | |
| SCHEMBL14767922 | 0.95 | ALDH1A1 (0.55) | ALDH1A1CYP19A1MAPTF7F3 | |
| SCHEMBL14767921 | 0.95 | ALDH1A1 (0.55) | ALDH1A1CYP19A1MAPTF7F3 | |
| SCHEMBL3224652 | 0.93 | ALDH1A1 (0.57) | ALDH1A1CYP19A1MAPTF7F3 | |
| SCHEMBL2984576 | 0.92 | ALDH1A1 (0.60) | ALDH1A1CYP19A1MAPTF7F3 | |
| SCHEMBL3213389 | 0.92 | ALDH1A1 (0.60) | ALDH1A1CYP19A1MAPTF7F3 | |
| SCHEMBL20553456 | 0.92 | ALDH1A1 (0.60) | ALDH1A1CYP19A1MAPTF7F3 | |
| SCHEMBL22635677 | 0.92 | ALDH1A1 (0.60) | ALDH1A1CYP19A1MAPTF7F3 | |
| SCHEMBL20553455 | 0.92 | ALDH1A1 (0.60) | ALDH1A1CYP19A1MAPTF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11684649-B2 | Use of magnolia figo extract in the manufacture of compound for reducing epidermal desquamation and promoting wound healing | FETHIANN MOLECULE APPLIED CO., LTD. (TW) | 2023-06-27 | — | — | US | claimed |
| EP-4000689-A1 | MAGNOLIA FIGO EXTRACT FOR USE IN REDUCING EPIDERMAL DESQUAMATION AND PROMOTING WOUND HEALING | Fethiann Molecule Applied Co., Ltd. (TW) | 2022-05-25 | — | — | EP | claimed |
| US-20220152141-A1 | USE OF MAGNOLIA FIGO EXTRACT IN THE MANUFACTURE OF COMPOUND FOR PROMOTING SKIN REPAIRING AND/OR WOUND HEALING | KUO, CHUN-SHENG (TW) | 2022-05-19 | — | — | US | claimed |
| US-11684649-B2 | Use of magnolia figo extract in the manufacture of compound for reducing epidermal desquamation and promoting wound healing | FETHIANN MOLECULE APPLIED CO., LTD. (TW) | 2023-06-27 | — | — | US | disclosed |
| EP-4000689-A1 | MAGNOLIA FIGO EXTRACT FOR USE IN REDUCING EPIDERMAL DESQUAMATION AND PROMOTING WOUND HEALING | Fethiann Molecule Applied Co., Ltd. (TW) | 2022-05-25 | — | — | EP | disclosed |
| US-20220152141-A1 | USE OF MAGNOLIA FIGO EXTRACT IN THE MANUFACTURE OF COMPOUND FOR PROMOTING SKIN REPAIRING AND/OR WOUND HEALING | KUO, CHUN-SHENG (TW) | 2022-05-19 | — | — | US | disclosed |
| US-20120083616-A1 | METHOD FOR PRODUCING A CONCENTRATE OF EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ACID ESTERS | GOLDEN OMEGA S.A. (CL) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11684649-B2 | Use of magnolia figo extract in the manufacture of compound for reducing epidermal desquamation and promoting wound healing | CUTA, ADM2, CD68 | ALDH1A1 3962/4885CYP19A1 818/4885MAPT 1321/4885 |
| US-20220152141-A1 | USE OF MAGNOLIA FIGO EXTRACT IN THE MANUFACTURE OF COMPOUND FOR PROMOTING SKIN REPAIRING AND/OR WOUND HEALING | CUTA, HMOX1, HMOX2 | ALDH1A1 3935/4885CYP19A1 857/4885MAPT 2257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.